Is BridgeBio Pharma, Inc. (BBIO) a Buy, Sell, or Hold?
BridgeBio Pharma, Inc.
NASDAQ:BBIO
$84.09 USD
$1.01 (1.22%)
- Volume
- 2.74M
- Average Volume
- 3.63M
- Market Capitalization
- $16.47B
- P/E Ratio
- -22.42
- Dividend Yield
- 0.00%
- Price Target
- $100.00
- Year High
- $93.42
- Year Low
- $42.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.44
BBIO vs. The Competition
| Properties | BBIO | ASND | BMRN | EXEL |
|---|---|---|---|---|
| Market Cap | $16.47B | $16.49B | $11.33B | $14.02B |
| Shares Outstanding | $195.86M | $62.11M | $193.28M | $251.36M |
| P/E Ratio | -22.42 | 28.37 | 41.89 | 17.87 |
| EPS | -3.73 | 8.21 | 1.4 | 3.23 |
| Day Low | 81.5 | 263.385 | 57.77 | 55.1 |
| Day high | 84.57 | 268.14 | 59.145 | 56.03 |
| Year Low | 42.09 | 160.86 | 49.26 | 33.76 |
| Year High | 93.415 | 282.15 | 66.28 | 57.57 |
| Average Price 50 | 70.1827 | 239.9672 | 55.5042 | 51.6474 |
| Average Price 200 | 69.4849 | 222.89348 | 55.92195 | 44.76105 |
| Volume | 2.74M | 516.49K | 1.39M | 1.8M |
| Average Volume | - | - | - | - |